{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,25]],"date-time":"2026-03-25T21:15:22Z","timestamp":1774473322210,"version":"3.50.1"},"reference-count":156,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2024,8,28]],"date-time":"2024-08-28T00:00:00Z","timestamp":1724803200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2024,8,28]],"date-time":"2024-08-28T00:00:00Z","timestamp":1724803200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"DOI":"10.13039\/501100011011","name":"Junta de Andaluc\u00eda","doi-asserted-by":"publisher","award":["USE 23922-W"],"award-info":[{"award-number":["USE 23922-W"]}],"id":[{"id":"10.13039\/501100011011","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001871","name":"Funda\u00e7\u00e3o para a Ci\u00eancia e a Tecnologia","doi-asserted-by":"publisher","award":["UIDP\/04378\/2020 AND UIDB\/04378\/2020"],"award-info":[{"award-number":["UIDP\/04378\/2020 AND UIDB\/04378\/2020"]}],"id":[{"id":"10.13039\/501100001871","id-type":"DOI","asserted-by":"publisher"}]},{"name":"ASSOCIATE LABORATORY INSTITUTE FOR HEALTH AND BIOECONOMY","award":["LA\/P\/0140\/2020"],"award-info":[{"award-number":["LA\/P\/0140\/2020"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["World J Pediatr"],"published-print":{"date-parts":[[2025,1]]},"DOI":"10.1007\/s12519-024-00834-x","type":"journal-article","created":{"date-parts":[[2024,8,28]],"date-time":"2024-08-28T03:40:04Z","timestamp":1724816404000},"page":"8-28","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":9,"title":["Next-generation pediatric care: nanotechnology-based and AI-driven solutions for cardiovascular, respiratory, and gastrointestinal disorders"],"prefix":"10.1007","volume":"21","author":[{"given":"Waldenice","family":"de Alencar Morais Lima","sequence":"first","affiliation":[]},{"given":"Jackson G.","family":"de Souza","sequence":"additional","affiliation":[]},{"given":"F\u00e1tima","family":"Garc\u00eda-Vill\u00e9n","sequence":"additional","affiliation":[]},{"given":"Julia Lira","family":"Loureiro","sequence":"additional","affiliation":[]},{"given":"Fernanda Nervo","family":"Raffin","sequence":"additional","affiliation":[]},{"given":"Marcelo A. C.","family":"Fernandes","sequence":"additional","affiliation":[]},{"given":"Eliana B.","family":"Souto","sequence":"additional","affiliation":[]},{"given":"Patricia","family":"Severino","sequence":"additional","affiliation":[]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3798-5512","authenticated-orcid":false,"given":"Raquel de M.","family":"Barbosa","sequence":"additional","affiliation":[]}],"member":"297","published-online":{"date-parts":[[2024,8,28]]},"reference":[{"key":"834_CR1","unstructured":"WHO. Child mortality and causes of death. 2023. Available from: https:\/\/www.who.int\/data\/gho\/data\/themes\/topics\/topic-details\/GHO\/child-mortality-and-causes-of-death. Accessed 30 Oct 2023."},{"key":"834_CR2","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1590\/1980-5497201700050005","volume":"20","author":"EB Fran\u00e7a","year":"2017","unstructured":"Fran\u00e7a EB, Lansky S, Rego MAS, Malta DC, Fran\u00e7a JS, Teixeira R, et al. Principais causas da mortalidade na inf\u00e2ncia no Brasil, em 1990 e 2015: estimativas do estudo de Carga Global de Doen\u00e7a. Rev Bras Epidemiol. 2017;20:46\u201360.","journal-title":"Rev Bras Epidemiol"},{"key":"834_CR3","doi-asserted-by":"crossref","first-page":"1234","DOI":"10.1002\/ppul.24351","volume":"54","author":"C Divecha","year":"2019","unstructured":"Divecha C, Tullu MS, Chaudhary S. Burden of respiratory illnesses in pediatric intensive care unit and predictors of mortality: experience from a low resource country. Pediatr Pulmonol. 2019;54:1234\u201341.","journal-title":"Pediatr Pulmonol"},{"key":"834_CR4","doi-asserted-by":"crossref","first-page":"1608","DOI":"10.3748\/wjg.v23.i9.1608","volume":"23","author":"TM Attard","year":"2017","unstructured":"Attard TM, Miller M, Pant C, Kumar A, Thomson M. Mortality associated with gastrointestinal bleeding in children: a retrospective cohort study. World J Gastroenterol. 2017;23:1608.","journal-title":"World J Gastroenterol"},{"key":"834_CR5","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1016\/S2352-4642(18)30095-6","volume":"2","author":"HH Kyu","year":"2018","unstructured":"Kyu HH, Stein CE, Boschi Pinto C, Rakovac I, Weber MW, Dannemann Purnat T, et al. Causes of death among children aged 5\u201314\u00a0years in the WHO European Region: a systematic analysis for the Global Burden of Disease Study 2016. Lancet Child Adolesc Heal. 2018;2:321\u201337.","journal-title":"Lancet Child Adolesc Heal"},{"key":"834_CR6","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1016\/j.addr.2013.08.011","volume":"73","author":"JKW Lam","year":"2014","unstructured":"Lam JKW, Xu Y, Worsley A, Wong ICK. Oral transmucosal drug delivery for pediatric use. Adv Drug Deliv Rev. 2014;73:50\u201362.","journal-title":"Adv Drug Deliv Rev"},{"key":"834_CR7","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1016\/j.addr.2019.08.008","volume":"151\u2013152","author":"VK Yellepeddi","year":"2019","unstructured":"Yellepeddi VK, Joseph A, Nance E. Pharmacokinetics of nanotechnology-based formulations in pediatric populations. Adv Drug Deliv Rev. 2019;151\u2013152:44\u201355.","journal-title":"Adv Drug Deliv Rev"},{"key":"834_CR8","doi-asserted-by":"crossref","first-page":"1122","DOI":"10.1007\/s12325-018-0732-y","volume":"35","author":"H Nir-Neuman","year":"2018","unstructured":"Nir-Neuman H, Abu-Kishk I, Toledano M, Heyman E, Ziv-Baran T, Berkovitch M. Unlicensed and off-label medication use in pediatric and neonatal intensive care units: no change over a decade. Adv Ther. 2018;35:1122\u201332.","journal-title":"Adv Ther"},{"key":"834_CR9","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1542\/peds.2013-3225","volume":"134","author":"V Ivanovska","year":"2014","unstructured":"Ivanovska V, Rademaker CMA, Van Dijk L, Mantel-Teeuwisse AK. Pediatric drug formulations: review of challenges and progress. Pediatrics. 2014;134:361\u201372.","journal-title":"Pediatrics"},{"key":"834_CR10","first-page":"776","volume":"111","author":"HC Allen","year":"2018","unstructured":"Allen HC, Garbe MC, Lees J, Aziz N, Chaaban H, Miller JL, et al. Off-label medication use in children, more common than we think: a systematic review of the literature. J Okla State Med Assoc. 2018;111:776.","journal-title":"J Okla State Med Assoc"},{"key":"834_CR11","doi-asserted-by":"crossref","DOI":"10.1016\/j.heliyon.2023.e15109","volume":"9","author":"AE Kasahun","year":"2023","unstructured":"Kasahun AE, Sendekie AK. Are pediatrics taking the prescribed tablet dosage form? Practices of off-label tablet modification in pediatric wards: a prospective observational study. Heliyon. 2023;9:e15109.","journal-title":"Heliyon"},{"key":"834_CR12","first-page":"1","volume":"12","author":"M Rautamo","year":"2020","unstructured":"Rautamo M, Kvarnstr\u00f6m K, Siv\u00e9n M, Airaksinen M, Lahdenne P, Sandler N. A focus group study about oral drug administration practices at hospital wards\u2014aspects to consider in drug development of age-appropriate formulations for children. Pharmaceutics. 2020;12:1\u201313.","journal-title":"Pharmaceutics"},{"key":"834_CR13","doi-asserted-by":"crossref","first-page":"1243","DOI":"10.1002\/cpt.2736","volume":"112","author":"TM van der Zanden","year":"2022","unstructured":"van der Zanden TM, Smeets NJL, de Hoop-Sommen M, Schwerzel MFT, Huang HJ, Barten LJC, et al. Off-label, but on-evidence? a review of the level of evidence for pediatric pharmacotherapy. Clin Pharmacol Ther. 2022;112:1243\u201353.","journal-title":"Clin Pharmacol Ther"},{"key":"834_CR14","doi-asserted-by":"crossref","first-page":"155","DOI":"10.7324\/JAPS.2020.10718","volume":"10","author":"AD Galande","year":"2020","unstructured":"Galande AD, Khurana NA, Mutalik S. Pediatric dosage forms - challenges and recent developments: a critical review. J Appl Pharm Sci. 2020;10:155\u201366.","journal-title":"J Appl Pharm Sci"},{"key":"834_CR15","volume":"75","author":"MS Marques","year":"2022","unstructured":"Marques MS, Lima LA, Poletto F, Contri RV, Kulkamp Guerreiro IC. Nanotechnology for the treatment of paediatric diseases: a review. J Drug Deliv Sci Technol. 2022;75: 103628.","journal-title":"J Drug Deliv Sci Technol"},{"key":"834_CR16","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1007\/s11096-021-01303-5","volume":"44","author":"B Guidi","year":"2022","unstructured":"Guidi B, Parziale A, Nocco L, Maiese A, La Russa R, Di Paolo M, et al. Regulating pediatric off-label uses of medicines in the EU and USA: challenges and potential solutions: Comparative regulation framework of off label prescriptions in pediatrics: a review. Int J Clin Pharm. 2022;44:264\u20139.","journal-title":"Int J Clin Pharm"},{"key":"834_CR17","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1016\/j.curtheres.2018.12.001","volume":"90","author":"C Spadoni","year":"2019","unstructured":"Spadoni C. Pediatric drug development: challenges and opportunities. Curr Ther Res. 2019;90:119\u201322.","journal-title":"Curr Ther Res"},{"key":"834_CR18","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1208\/s12249-023-02501-2","volume":"24","author":"MH Asfour","year":"2023","unstructured":"Asfour MH, Abd El-Alim SH, Kassem AA, Salama A, Gouda AS, Nazim WS, et al. Vitamin D3-loaded nanoemulsions as a potential drug delivery system for autistic children: formulation development, safety, and pharmacokinetic studies. AAPS PharmSciTech. 2023;24:58.","journal-title":"AAPS PharmSciTech"},{"key":"834_CR19","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1007\/s13233-021-9040-5","volume":"29","author":"S Been","year":"2021","unstructured":"Been S, Choi J, Lee YH, Kim PY, Kim WK, Cho HH, et al. Improvement of medication adherence and controlled drug release by optimized acetaminophen formulation. Macromol Res. 2021;29:342\u201350.","journal-title":"Macromol Res"},{"key":"834_CR20","volume":"182","author":"EA Kean","year":"2023","unstructured":"Kean EA, Adeleke OA. Orally disintegrating drug carriers for paediatric pharmacotherapy. Eur J Pharm Sci. 2023;182:106377.","journal-title":"Eur J Pharm Sci"},{"key":"834_CR21","doi-asserted-by":"crossref","first-page":"438","DOI":"10.1111\/anae.15650","volume":"77","author":"O Yoo","year":"2022","unstructured":"Yoo O, Tang EKY, Salman S, Nguyen MN, Sommerfield D, Sommerfield A, et al. A randomised controlled trial of a novel tramadol chewable tablet: pharmacokinetics and tolerability in children. Anaesthesia. 2022;77:438\u201348.","journal-title":"Anaesthesia"},{"key":"834_CR22","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijpharm.2019.118820","volume":"572","author":"V Laquintana","year":"2019","unstructured":"Laquintana V, Asim MH, Lopedota A, Cutrignelli A, Lopalco A, Franco M, et al. Thiolated hydroxypropyl-\u03b2-cyclodextrin as mucoadhesive excipient for oral delivery of budesonide in liquid paediatric formulation. Int J Pharm. 2019;572:118820.","journal-title":"Int J Pharm"},{"key":"834_CR23","doi-asserted-by":"crossref","first-page":"1910","DOI":"10.1080\/10717544.2018.1529209","volume":"25","author":"M Cirri","year":"2018","unstructured":"Cirri M, Maestrini L, Maestrelli F, Mennini N, Mura P, Ghelardini C, et al. Design, characterization and in vivo evaluation of nanostructured lipid carriers (NLC) as a new drug delivery system for hydrochlorothiazide oral administration in pediatric therapy. Drug Deliv. 2018;25:1910\u201321.","journal-title":"Drug Deliv"},{"key":"834_CR24","unstructured":"FDA. Reviews of pediatric studies conducted under BPCA and PREA from 2012\u2013present. 2023. Available: https:\/\/www.fda.gov\/drugs\/development-resources\/reviews-pediatric-studies-conducted-under-bpca-and-prea-2012-present. Accessed 30 Oct 2023."},{"key":"834_CR25","unstructured":"The Business Research Company. Theranostics Market Size, Trends, Growth | 2024 to 2033. 2024. Available: https:\/\/www.thebusinessresearchcompany.com\/report\/theranostics-global-market-report. Accessed 8 July 2024."},{"key":"834_CR26","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1038\/s41591-020-01197-2","volume":"27","author":"M May","year":"2021","unstructured":"May M. Eight ways machine learning is assisting medicine. Nat Med. 2021;27:2\u20133.","journal-title":"Nat Med"},{"key":"834_CR27","doi-asserted-by":"crossref","first-page":"745","DOI":"10.1590\/1806-9282.20220177","volume":"68","author":"FY Matsushita","year":"2022","unstructured":"Matsushita FY, Krebs VLJ, de Carvalho WB. Artificial intelligence and machine learning in pediatrics and neonatology healthcare. Rev Assoc Med Bras. 2022;68:745\u201350.","journal-title":"Rev Assoc Med Bras"},{"key":"834_CR28","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12913-020-05996-8","volume":"21","author":"J Cui","year":"2021","unstructured":"Cui J, Zhao L, Liu X, Liu M, Zhong L. Analysis of the potential inappropriate use of medications in pediatric outpatients in China. BMC Health Serv Res. 2021;21:1\u201312.","journal-title":"BMC Health Serv Res"},{"key":"834_CR29","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1016\/j.jpeds.2012.12.014","volume":"163","author":"LMA Houweling","year":"2013","unstructured":"Houweling LMA, Bezemer ID, Penning-Van Beest FJA, Meijer WM, Van Lingen RA, Herings RMC. First year of life medication use and hospital admission rates: premature compared with term infants. J Pediatr. 2013;163:61-6.e1.","journal-title":"J Pediatr"},{"issue":"9","key":"834_CR30","doi-asserted-by":"crossref","first-page":"e105110","DOI":"10.1371\/journal.pone.0105110","volume":"9","author":"S Schmiedl","year":"2014","unstructured":"Schmiedl S, Fischer R, Ibanez L, Fortuny J, Klungel OH, Reynolds R, et al. Utilisation and off-label prescriptions of respiratory drugs in children. PLoS ONE. 2014;9:e105110.","journal-title":"PLoS ONE"},{"key":"834_CR31","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1136\/fn.80.2.F142","volume":"80","author":"S Conroy","year":"1999","unstructured":"Conroy S, McIntyre J, Choonara I. Unlicensed and off label drug use in neonates. Arch Dis Child Fetal Neonatal Ed. 1999;80:142\u20135.","journal-title":"Arch Dis Child Fetal Neonatal Ed"},{"key":"834_CR32","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1183\/09031936.04.00015404","volume":"23","author":"GW Jong","year":"2004","unstructured":"Jong GW, Eland IA, Sturkenboom MCJM, van den Anker JN, Stricker BHC. Unlicensed and off-label prescription of respiratory drugs to children. Euro Respir J. 2004;23:310\u20133.","journal-title":"Euro Respir J"},{"key":"834_CR33","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1001\/archpedi.161.3.282","volume":"161","author":"SS Shah","year":"2007","unstructured":"Shah SS, Hall M, Goodman DM, Feuer P, Sharma V, Fargason C, et al. Off-label drug use in hospitalized children. Arch Pediatr Adolesc Med. 2007;161:282\u201390.","journal-title":"Arch Pediatr Adolesc Med"},{"key":"834_CR34","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1542\/hpeds.2018-0168","volume":"9","author":"K Yackey","year":"2019","unstructured":"Yackey K, Stukus K, Cohen D, Kline D, Zhao S, Stanley R. Off-label medication prescribing patterns in pediatrics: an update. Hosp Pediatr. 2019;9:186\u201393.","journal-title":"Hosp Pediatr"},{"key":"834_CR35","doi-asserted-by":"crossref","first-page":"678","DOI":"10.4187\/respcare.05360","volume":"62","author":"BA Kuch","year":"2017","unstructured":"Kuch BA, Saville AL, De Toledo JS, Venkataraman ST. Inhaled pulmonary vasodilators: are there indications within the pediatric ICU? Respir Care. 2017;62:678\u201398.","journal-title":"Respir Care"},{"key":"834_CR36","unstructured":"Agency EM. ANNUAL REPORT 2022. 2022. Available: https:\/\/www.ema.europa.eu\/en\/annual-report\/2022\/index.html Accessed 8 July 2024."},{"key":"834_CR37","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s40824-019-0166-x","volume":"23","author":"D Chenthamara","year":"2019","unstructured":"Chenthamara D, Subramaniam S, Ramakrishnan SG, Krishnaswamy S, Essa MM, Lin FH, et al. Therapeutic efficacy of nanoparticles and routes of administration. Biomater Res. 2019;23:1\u201329.","journal-title":"Biomater Res"},{"key":"834_CR38","doi-asserted-by":"crossref","first-page":"183","DOI":"10.3390\/nano10020183","volume":"10","author":"JF Pontes","year":"2020","unstructured":"Pontes JF, Grenha A. Multifunctional nanocarriers for lung drug delivery. Nanomaterials. 2020;10:183.","journal-title":"Nanomaterials"},{"key":"834_CR39","doi-asserted-by":"crossref","first-page":"1037","DOI":"10.1007\/s11095-022-03435-3","volume":"40","author":"L Qin","year":"2023","unstructured":"Qin L, Cui Z, Wu Y, Wang H, Zhang X, Guan J, et al. Challenges and strategies to enhance the systemic absorption of inhaled peptides and proteins. Pharm Res. 2023;40:1037\u201355.","journal-title":"Pharm Res"},{"key":"834_CR40","doi-asserted-by":"crossref","first-page":"588","DOI":"10.1046\/j.1365-2125.2003.01892.x","volume":"56","author":"NR Labiris","year":"2003","unstructured":"Labiris NR, Dolovich MB. Pulmonary drug delivery. Part I: physiological factors affecting therapeutic effectiveness of aerosolized medications. Br J Clin Pharmacol. 2003;56:588\u201399.","journal-title":"Br J Clin Pharmacol"},{"key":"834_CR41","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3390\/pharmaceutics11030113","volume":"11","author":"M Ghadiri","year":"2019","unstructured":"Ghadiri M, Young PM, Traini D. Strategies to enhance drug absorption via nasal and pulmonary routes. Pharmaceutics. 2019;11:1\u201320.","journal-title":"Pharmaceutics"},{"key":"834_CR42","doi-asserted-by":"crossref","first-page":"113953","DOI":"10.1016\/j.addr.2021.113953","volume":"177","author":"A Garc\u00eda-Fern\u00e1ndez","year":"2021","unstructured":"Garc\u00eda-Fern\u00e1ndez A, Sancen\u00f3n F, Mart\u00ednez-M\u00e1\u00f1ez R. Mesoporous silica nanoparticles for pulmonary drug delivery. Adv Drug Deliv Rev. 2021;177:113953.","journal-title":"Adv Drug Deliv Rev"},{"key":"834_CR43","doi-asserted-by":"crossref","first-page":"866","DOI":"10.3390\/pharmaceutics15030866","volume":"15","author":"L Shu","year":"2023","unstructured":"Shu L, Wang W, Ng C, Zhang X, Huang Y, Wu C, et al. A pilot study exploiting the industrialization potential of solid lipid nanoparticle-based metered-dose inhalers. Pharmaceutics. 2023;15:866.","journal-title":"Pharmaceutics"},{"key":"834_CR44","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1016\/j.jbiosc.2021.08.009","volume":"132","author":"J Chae","year":"2021","unstructured":"Chae J, Choi Y, Tanaka M, Choi J. Inhalable nanoparticles delivery targeting alveolar macrophages for the treatment of pulmonary tuberculosis. J Biosci Bioeng. 2021;132:543\u201351.","journal-title":"J Biosci Bioeng"},{"key":"834_CR45","doi-asserted-by":"crossref","first-page":"14792","DOI":"10.1021\/acsnano.2c05647","volume":"16","author":"J Kim","year":"2022","unstructured":"Kim J, Jozic A, Lin Y, Eygeris Y, Bloom E, Tan X, et al. Engineering lipid nanoparticles for enhanced intracellular delivery of mrna through inhalation. ACS Nano. 2022;16:14792\u2013806.","journal-title":"ACS Nano"},{"key":"834_CR46","doi-asserted-by":"crossref","first-page":"863","DOI":"10.1016\/j.addr.2007.11.006","volume":"60","author":"S Azarmi","year":"2008","unstructured":"Azarmi S, Roa WH, L\u00f6benberg R. Targeted delivery of nanoparticles for the treatment of lung diseases. Adv Drug Deliv Rev. 2008;60:863\u201375.","journal-title":"Adv Drug Deliv Rev"},{"key":"834_CR47","doi-asserted-by":"crossref","first-page":"1073","DOI":"10.2174\/1567201819666220426091500","volume":"19","author":"AS Tulbah","year":"2022","unstructured":"Tulbah AS. Inhaled atorvastatin nanoparticles for lung cancer. Curr Drug Deliv. 2022;19:1073\u201382.","journal-title":"Curr Drug Deliv"},{"key":"834_CR48","doi-asserted-by":"crossref","first-page":"2471","DOI":"10.2217\/nnm-2017-0188","volume":"12","author":"AS Tulbah","year":"2017","unstructured":"Tulbah AS, Pisano E, Scalia S, Young PM, Traini D, Ong HX. Inhaled simvastatin nanoparticles for inflammatory lung disease. Nanomedicine. 2017;12:2471\u201385.","journal-title":"Nanomedicine"},{"key":"834_CR49","first-page":"2179","volume":"10","author":"EWX Leong","year":"2022","unstructured":"Leong EWX, Ge R. Lipid nanoparticles as delivery vehicles for inhaled therapeutics. Biomed. 2022;10:2179.","journal-title":"Biomed"},{"key":"834_CR50","doi-asserted-by":"crossref","first-page":"1335","DOI":"10.1016\/j.msec.2016.08.024","volume":"69","author":"R Kumar","year":"2016","unstructured":"Kumar R, Siril PF, Javid F. Unusual anti-leukemia activity of nanoformulated naproxen and other non-steroidal anti-inflammatory drugs. Mater Sci Eng C Mater Biol Appl. 2016;69:1335\u201344.","journal-title":"Mater Sci Eng C Mater Biol Appl"},{"key":"834_CR51","volume":"53","author":"MD Buhecha","year":"2019","unstructured":"Buhecha MD, Lansley AB, Somavarapu S, Pannala AS. Development and characterization of PLA nanoparticles for pulmonary drug delivery: co-encapsulation of theophylline and budesonide, a hydrophilic and lipophilic drug. J Drug Deliv Sci Technol. 2019;53:101128.","journal-title":"J Drug Deliv Sci Technol"},{"key":"834_CR52","doi-asserted-by":"crossref","first-page":"1192","DOI":"10.1166\/mex.2023.2466","volume":"13","author":"S Yuan","year":"2023","unstructured":"Yuan S, Qian D, Su W. Fabrication of co-polymeric nanoformulation loaded with antibiotic ofloxacin and immunosuppressant tacrolimus for pediatric sepsis-induced acute lung injury. Mater Express. 2023;13:1192\u2013202.","journal-title":"Mater Express"},{"key":"834_CR53","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1016\/j.jconrel.2017.02.003","volume":"250","author":"J Rashid","year":"2017","unstructured":"Rashid J, Patel B, Nozik-Grayck E, McMurtry IF, Stenmark KR, Ahsan F. Inhaled sildenafil as an alternative to oral sildenafil in the treatment of pulmonary arterial hypertension (PAH). J Control Release. 2017;250:96\u2013106.","journal-title":"J Control Release"},{"key":"834_CR54","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1049\/mna2.12078","volume":"16","author":"H Li","year":"2021","unstructured":"Li H, Yao Y, Fu H. Novel pediatric suspension of nanoparticulate zafirlukast for the treatment of asthma: assessment and evaluation in animal model. Micro Nano Lett. 2021;16:485\u201391.","journal-title":"Micro Nano Lett"},{"key":"834_CR55","doi-asserted-by":"crossref","first-page":"1647","DOI":"10.1002\/jps.1115","volume":"90","author":"CF Lange","year":"2001","unstructured":"Lange CF, Hancock REW, Samuel J, Finlay WH. In vitro aerosol delivery and regional airway surface liquid concentration of a liposomal cationic peptide. J Pharm Sci. 2001;90:1647\u201357.","journal-title":"J Pharm Sci"},{"key":"834_CR56","first-page":"1","volume":"12","author":"H Zhang","year":"2020","unstructured":"Zhang H, Leal J, Soto MR, Smyth HDC, Ghosh D. Aerosolizable lipid nanoparticles for pulmonary delivery of mRNA through design of experiments. Pharmaceutics. 2020;12:1\u201316.","journal-title":"Pharmaceutics"},{"key":"834_CR57","doi-asserted-by":"crossref","first-page":"00225","DOI":"10.1016\/j.heliyon.2016.e00225","volume":"3","author":"VG Virginio","year":"2017","unstructured":"Virginio VG, Bandeira NC, dos Leal FMA, Lancellotti M, Zaha A, Ferreira HB. Assessment of the adjuvant activity of mesoporous silica nanoparticles in recombinant Mycoplasma hyopneumoniae antigen vaccines. Heliyon. 2017;3:00225.","journal-title":"Heliyon"},{"key":"834_CR58","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1161\/CIR.0000000000001151","volume":"148","author":"C Bogle","year":"2023","unstructured":"Bogle C, Colan SD, Miyamoto SD, Choudhry S, Baez-Hernandez N, Brickler MM, et al. Treatment strategies for cardiomyopathy in children: a scientific statement from the american heart association. Circulation. 2023;148:174\u201395.","journal-title":"Circulation"},{"key":"834_CR59","first-page":"74","volume":"1","author":"SK Pasquali","year":"2008","unstructured":"Pasquali SK, Hall M, Slonim AD, Jenkins KJ, Marino BS, Cohen MS, et al. Off-label use of cardiovascular medications in children hospitalized with congenital and acquired heart disease. Circ: Cardiovasc Qual Outcomes. 2008;1:74\u201383.","journal-title":"Circ: Cardiovasc Qual Outcomes"},{"key":"834_CR60","doi-asserted-by":"crossref","first-page":"775","DOI":"10.1007\/s00228-005-0981-y","volume":"61","author":"M Bajcetic","year":"2005","unstructured":"Bajcetic M, Jelisavcic M, Mitrovic J, Divac N, Simeunovic S, Samardzic R, et al. Off label and unlicensed drugs use in paediatric cardiology. Eur J Clin Pharmacol. 2005;61:775\u20139.","journal-title":"Eur J Clin Pharmacol"},{"key":"834_CR61","doi-asserted-by":"crossref","first-page":"772","DOI":"10.1111\/j.1651-2227.2012.02656.x","volume":"101","author":"E Kimland","year":"2012","unstructured":"Kimland E, Nydert P, Odlind V, B\u00f6ttiger Y, Lindemalm S. Paediatric drug use with focus on off-label prescriptions at Swedish hospitals\u2014a nationwide study. Acta Paediatr Int J Paediatr. 2012;101:772\u20138.","journal-title":"Acta Paediatr Int J Paediatr"},{"key":"834_CR62","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1097\/FJC.0b013e318213aac2","volume":"58","author":"K Watt","year":"2011","unstructured":"Watt K, Li JS, Benjamin DK, Cohen-Wolkowiez M. Pediatric cardiovascular drug dosing in critically ill children and extracorporeal membrane oxygenation. J Cardiovasc Pharmacol. 2011;58:126.","journal-title":"J Cardiovasc Pharmacol"},{"key":"834_CR63","volume":"632","author":"NM El-Sayed","year":"2023","unstructured":"El-Sayed NM, El-Bakary MA, Ibrahim MA, Elgamal MA, ElZorkany HES, Elshoky HA. Synthesis and characterization of mussel-inspired nanocomposites based on dopamine\u2013chitosan\u2013iron oxide for wound healing: in vitro study. Int J Pharm. 2023;632:122538.","journal-title":"Int J Pharm"},{"key":"834_CR64","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0120328","volume":"10","author":"H Kurobe","year":"2015","unstructured":"Kurobe H, Maxfield MW, Tara S, Rocco KA, Bagi PS, Yi T, et al. Development of small diameter nanofiber tissue engineered arterial grafts. PLoS ONE. 2015;10: e0120328.","journal-title":"PLoS ONE"},{"key":"834_CR65","doi-asserted-by":"crossref","first-page":"5679","DOI":"10.1016\/j.biomaterials.2014.03.067","volume":"35","author":"X Li","year":"2014","unstructured":"Li X, Zhou J, Liu Z, Chen J, L\u00fc S, Sun H, et al. A PNIPAAm-based thermosensitive hydrogel containing SWCNTs for stem cell transplantation in myocardial repair. Biomaterials. 2014;35:5679\u201388.","journal-title":"Biomaterials"},{"key":"834_CR66","first-page":"1","volume":"4","author":"J Zhou","year":"2014","unstructured":"Zhou J, Chen J, Sun H, Qiu X, Mou Y, Liu Z, et al. Engineering the heart: evaluation of conductive nanomaterials for improving implant integration and cardiac function. Sci Reports. 2014;4:1\u201311.","journal-title":"Sci Reports"},{"key":"834_CR67","doi-asserted-by":"crossref","DOI":"10.1016\/j.msec.2020.111354","volume":"118","author":"D Sridharan","year":"2021","unstructured":"Sridharan D, Palaniappan A, Blackstone BN, Dougherty JA, Kumar N, Seshagiri PB, et al. In situ differentiation of human-induced pluripotent stem cells into functional cardiomyocytes on a coaxial PCL-gelatin nanofibrous scaffold. Mater Sci Eng C. 2021;118:111354.","journal-title":"Mater Sci Eng C"},{"key":"834_CR68","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1007\/978-1-0716-0845-6_13","volume":"2193","author":"D Sridharan","year":"2021","unstructured":"Sridharan D, Palaniappan A, Blackstone BN, Powell HM, Khan M. Electrospun aligned coaxial nanofibrous scaffold for cardiac repair. Methods Mol Biol. 2021;2193:129\u201340.","journal-title":"Methods Mol Biol"},{"key":"834_CR69","doi-asserted-by":"crossref","first-page":"1157","DOI":"10.1038\/s41551-021-00796-9","volume":"5","author":"L Wang","year":"2021","unstructured":"Wang L, Liu Y, Ye G, He Y, Li B, Guan Y, et al. Injectable and conductive cardiac patches repair infarcted myocardium in rats and minipigs. Nat Biomed Eng. 2021;5:1157\u201373.","journal-title":"Nat Biomed Eng"},{"key":"834_CR70","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1016\/j.actbio.2022.05.003","volume":"146","author":"R Sun","year":"2022","unstructured":"Sun R, Wang X, Nie Y, Hu A, Liu H, Zhang K, et al. Targeted trapping of endogenous endothelial progenitor cells for myocardial ischemic injury repair through neutrophil-mediated SPIO nanoparticle-conjugated CD34 antibody delivery and imaging. Acta Biomater. 2022;146:421\u201333.","journal-title":"Acta Biomater"},{"key":"834_CR71","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1007\/s00431-012-1894-2","volume":"172","author":"D Zanon","year":"2013","unstructured":"Zanon D, Gallelli L, Rovere F, Paparazzo R, Maximova N, Lazzerini M, et al. Off-label prescribing patterns of antiemetics in children: a multicenter study in Italy. Eur J Pediatr. 2013;172:361\u20137.","journal-title":"Eur J Pediatr"},{"key":"834_CR72","doi-asserted-by":"crossref","first-page":"612","DOI":"10.1097\/MOP.0b013e328363ed4e","volume":"25","author":"A Karesh","year":"2013","unstructured":"Karesh A, Tomaino J, Mulberg AE. Off-label use of medicine in pediatrics: Focus on gastrointestinal diseases. Curr Opin Pediatr. 2013;25:612\u20137.","journal-title":"Curr Opin Pediatr"},{"key":"834_CR73","first-page":"205031212210965","volume":"10","author":"A Belayneh","year":"2022","unstructured":"Belayneh A, Abatneh E, Abebe D, Getachew M, Kebede B, Dessie B. Off-label medication use in pediatrics and associated factors at public hospitals in east Gojjam zone. Ethiopia SAGE Open Med. 2022;10:20503121221096536.","journal-title":"Ethiopia SAGE Open Med"},{"key":"834_CR74","doi-asserted-by":"crossref","first-page":"1244","DOI":"10.3889\/oamjms.2021.6931","volume":"9","author":"A Zhaksylyk","year":"2021","unstructured":"Zhaksylyk A, Nurbakyt A, Grjibovski A, Kaussova G, Buleshov M. Epidemiology of gastrointestinal disease among children and adolescents in Kazakhstan: 2012\u20132019. Open Access Maced J Med Sci. 2021;9:1244\u20139.","journal-title":"Open Access Maced J Med Sci"},{"key":"834_CR75","doi-asserted-by":"crossref","first-page":"870","DOI":"10.1016\/j.cgh.2017.11.005","volume":"16","author":"E Scarpato","year":"2018","unstructured":"Scarpato E, Kolacek S, Jojkic-Pavkov D, Konjik V, \u017divkovi\u0107 N, Roman E, et al. Prevalence of functional gastrointestinal disorders in children and adolescents in the Mediterranean Region of Europe. Clin Gastroenterol Hepatol. 2018;16:870\u20136.","journal-title":"Clin Gastroenterol Hepatol"},{"key":"834_CR76","doi-asserted-by":"crossref","first-page":"3749","DOI":"10.3390\/foods11233749","volume":"11","author":"C Blanco-Llamero","year":"2022","unstructured":"Blanco-Llamero C, Galindo-Camacho RM, Fonseca J, Santini A, Se\u00f1or\u00e1ns FJ, Souto EB. Development of lipid nanoparticles containing omega-3-rich extract of microalga nannochlorpsis gaditana. Foods. 2022;11:3749.","journal-title":"Foods"},{"key":"834_CR77","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1080\/08982104.2018.1529792","volume":"29","author":"YB Xing","year":"2019","unstructured":"Xing YB, Liu X, Li X, Ding F, Zhang JY, Guo XH. PEG-PCL modification and intestinal sustained-release of solid lipid nanoparticles for improving oral bioavailability of 2-methoxyestradiol. J Liposome Res. 2019;29:207\u201314.","journal-title":"J Liposome Res"},{"key":"834_CR78","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1016\/j.ejpb.2016.08.001","volume":"108","author":"S Doktorovov\u00e1","year":"2016","unstructured":"Doktorovov\u00e1 S, Kovacevic AB, Garcia ML, Souto EB. Preclinical safety of solid lipid nanoparticles and nanostructured lipid carriers: current evidence from in vitro and in vivo evaluation. Eur J Pharm Biopharm. 2016;108:235\u201352.","journal-title":"Eur J Pharm Biopharm"},{"key":"834_CR79","doi-asserted-by":"crossref","first-page":"124084","DOI":"10.1016\/j.ijbiomac.2023.124084","volume":"237","author":"AD Permana","year":"2023","unstructured":"Permana AD, Sam A, Marzaman ANF, Rahim A, Nainu F, Bahar MA, et al. Solid lipid nanoparticles cyclodextrin-decorated incorporated into gellan gum-based dry floating in situ delivery systems for controlled release of bioactive compounds of safflower (Carthamus tinctorius. L): a proof of concept study in biorelevant media. Int J Biol Macromol. 2023;237:124084.","journal-title":"Int J Biol Macromol"},{"key":"834_CR80","doi-asserted-by":"crossref","first-page":"802","DOI":"10.1016\/j.jconrel.2022.12.017","volume":"353","author":"KC de Castro","year":"2023","unstructured":"de Castro KC, Coco JC, dos Santos \u00c9M, Ataide JA, Martinez RM, do Nascimento MHM, et al. Pluronic\u00ae triblock copolymer-based nanoformulations for cancer therapy: a 10-year overview. J Control Release. 2023;353:802\u201322.","journal-title":"J Control Release"},{"key":"834_CR81","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1093\/ecco-jcc\/jjx115","volume":"12","author":"M Zhang","year":"2018","unstructured":"Zhang M, Xu C, Liu D, Han MK, Wang L, Merlina D. Oral delivery of nanoparticles loaded with ginger active compound, 6-shogaol, attenuates ulcerative colitis and promotes wound healing in a murine model of ulcerative colitis. J Crohns Colitis. 2018;12:217\u201329.","journal-title":"J Crohns Colitis"},{"key":"834_CR82","doi-asserted-by":"crossref","first-page":"821","DOI":"10.3390\/pharmaceutics15030821","volume":"15","author":"Y Ren","year":"2023","unstructured":"Ren Y, Qi C, Ruan S, Cao G, Ma Z, Zhang X. Selenized polymer-lipid hybrid nanoparticles for oral delivery of tripterine with ameliorative oral anti-enteritis activity and bioavailability. Pharmaceutics. 2023;15:821.","journal-title":"Pharmaceutics"},{"key":"834_CR83","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12951-021-00916-2","volume":"19","author":"J Diao","year":"2021","unstructured":"Diao J, Xia Y, Jiang X, Qiu J, Cheng S, Su J, et al. Silicon dioxide nanoparticles induced neurobehavioral impairments by disrupting microbiota\u2013gut\u2013brain axis. J Nanobiotechnology. 2021;19:1\u201320.","journal-title":"J Nanobiotechnology"},{"key":"834_CR84","doi-asserted-by":"crossref","first-page":"1301","DOI":"10.1080\/17435390.2020.1817597","volume":"14","author":"Y Gao","year":"2020","unstructured":"Gao Y, Ye Y, Wang J, Zhang H, Wu Y, Wang Y, et al. Effects of titanium dioxide nanoparticles on nutrient absorption and metabolism in rats: distinguishing the susceptibility of amino acids, metal elements, and glucose. Nanotoxicology. 2020;14:1301\u201323.","journal-title":"Nanotoxicology"},{"key":"834_CR85","volume":"312","author":"X Zhu","year":"2023","unstructured":"Zhu X, Li H, Zhou L, Jiang H, Ji M, Chen J. Evaluation of the gut microbiome alterations in healthy rats after dietary exposure to different synthetic ZnO nanoparticles. Life Sci. 2023;312:121250.","journal-title":"Life Sci"},{"key":"834_CR86","doi-asserted-by":"crossref","first-page":"660","DOI":"10.7150\/thno.8698","volume":"4","author":"MS Muthu","year":"2014","unstructured":"Muthu MS, Leong DT, Mei L, Feng SS. Nanotheranostics - application and further development of nanomedicine strategies for advanced theranostics. Theranostics. 2014;4:660\u201377.","journal-title":"Theranostics"},{"key":"834_CR87","doi-asserted-by":"crossref","first-page":"8798","DOI":"10.1016\/j.biomaterials.2013.07.084","volume":"34","author":"WH Chen","year":"2013","unstructured":"Chen WH, Xu XD, Jia HZ, Lei Q, Luo GF, Cheng SX, et al. Therapeutic nanomedicine based on dual-intelligent functionalized gold nanoparticles for cancer imaging and therapy invivo. Biomaterials. 2013;34:8798\u2013807.","journal-title":"Biomaterials"},{"key":"834_CR88","doi-asserted-by":"crossref","first-page":"3946","DOI":"10.1021\/mp400397t","volume":"10","author":"O Taratula","year":"2013","unstructured":"Taratula O, Schumann C, Naleway MA, Pang AJ, Chon KJ, Taratula O. A multifunctional theranostic platform based on phthalocyanine-loaded dendrimer for image-guided drug delivery and photodynamic therapy. Mol Pharm. 2013;10:3946\u201358.","journal-title":"Mol Pharm"},{"key":"834_CR89","doi-asserted-by":"crossref","first-page":"5663","DOI":"10.1016\/j.biomaterials.2011.04.037","volume":"32","author":"P Chandrasekharan","year":"2011","unstructured":"Chandrasekharan P, Maity D, Yong CX, Chuang KH, Ding J, Feng SS. Vitamin E (d-alpha-tocopheryl-co-poly(ethylene glycol) 1000 succinate) micelles-superparamagnetic iron oxide nanoparticles for enhanced thermotherapy and MRI. Biomaterials. 2011;32:5663\u201372.","journal-title":"Biomaterials"},{"key":"834_CR90","doi-asserted-by":"crossref","first-page":"3494","DOI":"10.1016\/j.biomaterials.2012.01.036","volume":"33","author":"MS Muthu","year":"2012","unstructured":"Muthu MS, Kulkarni SA, Raju A, Feng SS. Theranostic liposomes of TPGS coating for targeted co-delivery of docetaxel and quantum dots. Biomaterials. 2012;33:3494\u2013501.","journal-title":"Biomaterials"},{"key":"834_CR91","doi-asserted-by":"crossref","first-page":"779","DOI":"10.1007\/s12274-010-0045-1","volume":"3","author":"JT Robinson","year":"2010","unstructured":"Robinson JT, Welsher K, Tabakman SM, Sherlock SP, Wang H, Luong R, et al. High performance in vivo near-IR (>1\u00a0\u03bcm) imaging and photothermal cancer therapy with carbon nanotubes. Nano Res. 2010;3:779\u201393.","journal-title":"Nano Res"},{"key":"834_CR92","doi-asserted-by":"crossref","first-page":"347","DOI":"10.2217\/nnm.10.13","volume":"5","author":"J Pan","year":"2010","unstructured":"Pan J, Liu Y, Feng SS. Multifunctional nanoparticles of biodegradable copolymer blend for cancer diagnosis and treatment. Nanomedicine (Lond). 2010;5:347\u201360.","journal-title":"Nanomedicine (Lond)"},{"key":"834_CR93","doi-asserted-by":"crossref","first-page":"346","DOI":"10.3390\/jnt4030016","volume":"4","author":"PA Akpa","year":"2023","unstructured":"Akpa PA, Peter IE, Onwuka AM, Obi BC, Akunne MO, Nworu CS, et al. Nanotheranostics: platforms, current applications, and mechanisms of targeting in breast and prostate cancers. J Nanotheranostics. 2023;4:346\u201383.","journal-title":"J Nanotheranostics"},{"key":"834_CR94","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1586\/erm.13.15","volume":"13","author":"TH Kim","year":"2013","unstructured":"Kim TH, Lee S, Chen X. Nanotheranostics for personalized medicine. Expert Rev Mol Diagn. 2013;13:257\u201369.","journal-title":"Expert Rev Mol Diagn"},{"key":"834_CR95","doi-asserted-by":"crossref","first-page":"2101","DOI":"10.1021\/mp200394t","volume":"8","author":"R Duncan","year":"2011","unstructured":"Duncan R, Gaspar R. Nanomedicine (s) under the microscope. Mole Pharm. 2011;8:2101\u201341.","journal-title":"Mole Pharm"},{"key":"834_CR96","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/j.jconrel.2015.09.060","volume":"218","author":"H Moon","year":"2015","unstructured":"Moon H, Kang J, Sim C, Kim J, Lee H, Chang JH, et al. Multifunctional theranostic contrast agent for photoacoustics- and ultrasound-based tumor diagnosis and ultrasound-stimulated local tumor therapy. J Control Release. 2015;218:63\u201371.","journal-title":"J Control Release"},{"key":"834_CR97","first-page":"217","volume":"23","author":"FM Kievit","year":"2011","unstructured":"Kievit FM, Zhang M. Cancer nanotheranostics: Improving imaging and therapy by targeted delivery across biological barriers. Adv Mater. 2011;23:217\u201347.","journal-title":"Adv Mater"},{"key":"834_CR98","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1016\/j.molmed.2010.09.004","volume":"16","author":"EC Cho","year":"2010","unstructured":"Cho EC, Glaus C, Chen J, Welch MJ, Xia Y. Inorganic nanoparticle-based contrast agents for molecular imaging. Trends Mol Med. 2010;16:561\u201373.","journal-title":"Trends Mol Med"},{"key":"834_CR99","doi-asserted-by":"crossref","first-page":"352","DOI":"10.1007\/s13346-013-0132-4","volume":"3","author":"M Howell","year":"2013","unstructured":"Howell M, Wang C, Mahmoud A, Hellermann G, Mohapatra SS, Mohapatra S. Dual-function theranostic nanoparticles for drug delivery and medical imaging contrast: perspectives and challenges for use in lung diseases. Drug Deliv Transl Res. 2013;3:352\u201363.","journal-title":"Drug Deliv Transl Res"},{"key":"834_CR100","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3389\/fonc.2020.00001","volume":"10","author":"AJ Poot","year":"2020","unstructured":"Poot AJ, Lam MGEH, van Noesel MM. The current status and future potential of theranostics to diagnose and treat childhood cancer. Front Oncol. 2020;10:1\u20138.","journal-title":"Front Oncol"},{"key":"834_CR101","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1093\/neuonc\/noad073.181","volume":"25","author":"S Plasschaert","year":"2023","unstructured":"Plasschaert S, Tolboom N, Kester L, Tops B, Hoving E, Poot A, et al. IMG-04. Potential targets for theranostics in pediatric high-grade central nervous system (CNS) tumors. Neuro Oncol. 2023;25:47.","journal-title":"Neuro Oncol"},{"key":"834_CR102","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1016\/j.nucmedbio.2022.09.001","volume":"114\u2013115","author":"VJA Niessen","year":"2022","unstructured":"Niessen VJA, Wenker STM, Lam MGEH, van Noesel MM, Poot AJ. Biologicals as theranostic vehicles in paediatric oncology. Nucl Med Biol. 2022;114\u2013115:58\u201364.","journal-title":"Nucl Med Biol"},{"key":"834_CR103","doi-asserted-by":"crossref","first-page":"325","DOI":"10.3892\/mmr.2021.11964","volume":"23","author":"MX Luo","year":"2021","unstructured":"Luo MX, Hua S, Shang QY. Application of nanotechnology in drug delivery systems for respiratory diseases (Review). Mol Med Rep. 2021;23:325.","journal-title":"Mol Med Rep"},{"key":"834_CR104","doi-asserted-by":"crossref","first-page":"1696","DOI":"10.1021\/nn800275r","volume":"2","author":"L Zhang","year":"2008","unstructured":"Zhang L, Chan JM, Gu FX, Rhee JW, Wang AZ, Radovic-Moreno AF, et al. Self-assembled lipid-polymer hybrid nanoparticles: a robust drug delivery platform. ACS Nano. 2008;2:1696\u2013702.","journal-title":"ACS Nano"},{"key":"834_CR105","doi-asserted-by":"crossref","first-page":"1919","DOI":"10.1002\/smll.201100442","volume":"7","author":"J Wang","year":"2011","unstructured":"Wang J, Byrne JD, Napier ME, Desimone JM. More effective nanomedicines through particle design. Small. 2011;7:1919\u201331.","journal-title":"Small"},{"key":"834_CR106","doi-asserted-by":"crossref","first-page":"2108","DOI":"10.1002\/smll.200800922","volume":"4","author":"M Semmler-Behnke","year":"2008","unstructured":"Semmler-Behnke M, Kreyling WG, Lipka J, Fertsch S, Wenk A, Takenaka S, et al. Biodistribution of 1.4- and 18-nm gold particles in rats. Small. 2008;4:2108\u201311.","journal-title":"Small"},{"key":"834_CR107","doi-asserted-by":"crossref","first-page":"370","DOI":"10.1002\/cmmi.439","volume":"6","author":"W Li","year":"2011","unstructured":"Li W, Brown PK, Wang LV, Xia Y. Gold nanocages as contrast agents for photoacoustic imaging. Contrast Media Mol Imaging. 2011;6:370\u20137.","journal-title":"Contrast Media Mol Imaging"},{"key":"834_CR108","first-page":"1","volume":"30","author":"C Wang","year":"2018","unstructured":"Wang C, Wang Y, Zhang L, Miron RJ, Liang J, Shi M, et al. Pretreated macrophage-membrane-coated gold nanocages for precise drug delivery for treatment of bacterial infections. Adv Mater. 2018;30:1\u20138.","journal-title":"Adv Mater"},{"key":"834_CR109","doi-asserted-by":"crossref","first-page":"1579","DOI":"10.1016\/j.chest.2019.11.036","volume":"157","author":"H Wang","year":"2020","unstructured":"Wang H, Wu L, Sun X. Intratracheal delivery of nano- and microparticles and hyperpolarized gases: a promising strategy for the imaging and treatment of respiratory disease. Chest. 2020;157:1579\u201390.","journal-title":"Chest"},{"key":"834_CR110","doi-asserted-by":"crossref","first-page":"1","DOI":"10.4103\/bbrj.bbrj_54_17","volume":"1","author":"H Suer","year":"2017","unstructured":"Suer H, Bayram H. Liposomes as potential nanocarriers for theranostic applications in chronic inflammatory lung diseases. Biomed Biotechnol Res J. 2017;1:1\u20138.","journal-title":"Biomed Biotechnol Res J"},{"key":"834_CR111","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1007\/s10557-020-07016-7","volume":"35","author":"V Jani","year":"2021","unstructured":"Jani V, Shivaram P, Porter TR, Kutty S. Ultrasound theranostics in adult and pediatric cardiovascular research. Cardiovasc Drugs Ther. 2021;35:185\u201390.","journal-title":"Cardiovasc Drugs Ther"},{"key":"834_CR112","doi-asserted-by":"crossref","first-page":"1001","DOI":"10.1016\/j.echo.2010.06.024","volume":"23","author":"S Kutty","year":"2010","unstructured":"Kutty S, Xie F, Gao S, Drvol LK, Lof J, Fletcher SE, et al. Sonothrombolysis of intra-catheter aged venous thrombi using microbubble enhancement and guided three-dimensional ultrasound pulses. J Am Soc Echocardiogr. 2010;23:1001\u20136.","journal-title":"J Am Soc Echocardiogr"},{"key":"834_CR113","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/1878-5085-4-1","volume":"4","author":"MY Spivak","year":"2013","unstructured":"Spivak MY, Bubnov RV, Yemets IM, Lazarenko LM, Tymoshok NO, Ulberg ZR. Development and testing of gold nanoparticles for drug delivery and treatment of heart failure: a theranostic potential for PPP cardiology. EPMA J. 2013;4:1\u201323.","journal-title":"EPMA J"},{"key":"834_CR114","doi-asserted-by":"crossref","first-page":"1785","DOI":"10.1016\/j.drudis.2022.05.026","volume":"27","author":"P Zhan","year":"2022","unstructured":"Zhan P, Yu B, Ouyang L. Drug repurposing: an effective strategy to accelerate contemporary drug discovery. Drug Discov Today. 2022;27:1785\u20138.","journal-title":"Drug Discov Today"},{"key":"834_CR115","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1038\/nrd1468","volume":"3","author":"TT Ashburn","year":"2004","unstructured":"Ashburn TT, Thor KB. Drug repositioning: identifying and developing new uses for existing drugs. Nat Rev Drug Discov. 2004;3:673\u201383.","journal-title":"Nat Rev Drug Discov"},{"key":"834_CR116","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1038\/nrd.2018.168","volume":"18","author":"S Pushpakom","year":"2018","unstructured":"Pushpakom S, Iorio F, Eyers PA, Escott KJ, Hopper S, Wells A, et al. Drug repurposing: progress, challenges and recommendations. Nat Rev Drug Discov. 2018;18:41\u201358.","journal-title":"Nat Rev Drug Discov"},{"key":"834_CR117","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1038\/534314a","volume":"534","author":"N Nosengo","year":"2016","unstructured":"Nosengo N. Can you teach old drugs new tricks? Nature. 2016;534:314\u20136.","journal-title":"Nature"},{"key":"834_CR118","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1038\/nrd3681","volume":"11","author":"JW Scannell","year":"2012","unstructured":"Scannell JW, Blanckley A, Boldon H, Warrington B. Diagnosing the decline in pharmaceutical R&D efficiency. Nat Rev Drug Discov. 2012;11:191\u2013200.","journal-title":"Nat Rev Drug Discov"},{"key":"834_CR119","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12913-022-08272-z","volume":"22","author":"N Krishnamurthy","year":"2022","unstructured":"Krishnamurthy N, Grimshaw AA, Axson SA, Choe SH, Miller JE. Drug repurposing: a systematic review on root causes, barriers and facilitators. BMC Health Serv Res. 2022;22:1\u201317.","journal-title":"BMC Health Serv Res"},{"key":"834_CR120","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s13063-021-05273-x","volume":"22","author":"C Verbaanderd","year":"2021","unstructured":"Verbaanderd C, Rooman I, Huys I. Exploring new uses for existing drugs: innovative mechanisms to fund independent clinical research. Trials. 2021;22:1\u201313.","journal-title":"Trials"},{"key":"834_CR121","doi-asserted-by":"crossref","DOI":"10.1016\/j.drudis.2022.103396","volume":"27","author":"PC Albuquerque","year":"2022","unstructured":"Albuquerque PC, Zicker F, Fonseca BP. Advancing drug repurposing research: trends, collaborative networks, innovation and knowledge leaders. Drug Discov Today. 2022;27:103396.","journal-title":"Drug Discov Today"},{"key":"834_CR122","doi-asserted-by":"crossref","DOI":"10.3389\/fphys.2020.568632","volume":"11","author":"M Schubert","year":"2020","unstructured":"Schubert M, Hansen S, Leefmann J, Guan K. Repurposing antidiabetic drugs for cardiovascular disease. Front Physiol. 2020;11:568632.","journal-title":"Front Physiol"},{"key":"834_CR123","first-page":"1","volume":"26","author":"E Tejera","year":"2021","unstructured":"Tejera E, P\u00e9rez-Castillo Y, Chamorro A, Cabrera-Andrade A, Sanchez ME. A multi-objective approach for drug repurposing in preeclampsia. Molecules. 2021;26:1\u201319.","journal-title":"Molecules"},{"key":"834_CR124","volume":"11","author":"E Fern\u00e1ndez \u00c1lvaro","year":"2022","unstructured":"Fern\u00e1ndez \u00c1lvaro E, Voong Vinh P, de Cozar C, Will\u00e9 DR, Urones B, Cort\u00e9s A, et al. The repurposing of Tebipenem pivoxil as alternative therapy for severe gastrointestinal infections caused by extensively drug-resistant Shigella spp (eLife (2022) 11 PII: e83117). Elife. 2022;11:e69798.","journal-title":"Elife"},{"key":"834_CR125","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1080\/17460441.2023.2199980","volume":"18","author":"AA Ezat","year":"2023","unstructured":"Ezat AA, Abduljalil JM, Elghareib AM, Samir A, Elfiky AA. The discovery of novel antivirals for the treatment of mpox: is drug repurposing the answer? Expert Opin Drug Discov. 2023;18:551\u201361.","journal-title":"Expert Opin Drug Discov"},{"key":"834_CR126","doi-asserted-by":"crossref","first-page":"75","DOI":"10.3390\/v15010075","volume":"15","author":"R Yan","year":"2022","unstructured":"Yan R, He J, Liu G, Zhong J, Xu J, Zheng K, et al. Drug repositioning for hand, foot, and mouth disease. Viruses. 2022;15:75.","journal-title":"Viruses"},{"key":"834_CR127","doi-asserted-by":"crossref","DOI":"10.1002\/ardp.202200214","volume":"355","author":"DS Reddy","year":"2022","unstructured":"Reddy DS, Sinha A, Kumar A, Saini VK. Drug re-engineering and repurposing: a significant and rapid approach to tuberculosis drug discovery. Arch Pharm (Weinheim). 2022;355:e2200214.","journal-title":"Arch Pharm (Weinheim)"},{"key":"834_CR128","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/msb.2011.26","volume":"7","author":"A Gottlieb","year":"2011","unstructured":"Gottlieb A, Stein GY, Ruppin E, Sharan R. PREDICT: a method for inferring novel drug indications with application to personalized medicine. Mol Syst Biol. 2011;7:1\u20139.","journal-title":"Mol Syst Biol"},{"key":"834_CR129","doi-asserted-by":"crossref","first-page":"59","DOI":"10.12793\/tcp.2019.27.2.59","volume":"27","author":"K Park","year":"2019","unstructured":"Park K. A review of computational drug repurposing. Transl Clin Pharmacol. 2019;27:59\u201363.","journal-title":"Transl Clin Pharmacol"},{"key":"834_CR130","doi-asserted-by":"crossref","first-page":"537","DOI":"10.2174\/1389203718666161108091609","volume":"19","author":"S Anusuya","year":"2018","unstructured":"Anusuya S, Kesherwani M, Priya KV, Vimala A, Shanmugam G, Velmurugan D, et al. Drug-target interactions: prediction methods and applications. Curr Protein Pept Sci. 2018;19:537\u201361.","journal-title":"Curr Protein Pept Sci"},{"key":"834_CR131","doi-asserted-by":"crossref","first-page":"103159","DOI":"10.1016\/j.jbi.2019.103159","volume":"93","author":"K Sachdev","year":"2019","unstructured":"Sachdev K, Gupta MK. A comprehensive review of feature based methods for drug target interaction prediction. J Biomed Inform. 2019;93:103159.","journal-title":"J Biomed Inform"},{"key":"834_CR132","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1089\/cmb.2017.0135","volume":"25","author":"L Wang","year":"2018","unstructured":"Wang L, You ZH, Chen X, Xia SX, Liu F, Yan X, et al. A computational-based method for predicting drug-target interactions by using stacked autoencoder deep neural network. J Comput Biol. 2018;25:361\u201373.","journal-title":"J Comput Biol"},{"key":"834_CR133","doi-asserted-by":"crossref","first-page":"784","DOI":"10.1016\/j.csbj.2020.03.025","volume":"18","author":"BR Beck","year":"2020","unstructured":"Beck BR, Shin B, Choi Y, Park S, Kang K. Predicting commercially available antiviral drugs that may act on the novel coronavirus (SARS-CoV-2) through a drug-target interaction deep learning model. Comput Struct Biotechnol J. 2020;18:784\u201390.","journal-title":"Comput Struct Biotechnol J"},{"key":"834_CR134","doi-asserted-by":"crossref","first-page":"1140","DOI":"10.1093\/bioinformatics\/btaa921","volume":"37","author":"T Nguyen","year":"2021","unstructured":"Nguyen T, Le H, Quinn TP, Nguyen T, Le TD, Venkatesh S. GraphDTA: predicting drug target binding affinity with graph neural networks. Bioinformatics. 2021;37:1140\u20137.","journal-title":"Bioinformatics"},{"key":"834_CR135","first-page":"1","volume":"106","author":"B Shin","year":"2019","unstructured":"Shin B, Park S, Kang K, Ho JC. Self-attention based molecule representation for predicting drug-target interaction. Proc Mach Learn Res. 2019;106:1\u201318.","journal-title":"Proc Mach Learn Res"},{"key":"834_CR136","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3389\/fphar.2018.00001","volume":"9","author":"Z Wu","year":"2018","unstructured":"Wu Z, Li W, Liu G, Tang Y. Network-based methods for prediction of drug-target interactions. Front Pharmacol. 2018;9:1\u201314.","journal-title":"Front Pharmacol"},{"key":"834_CR137","first-page":"1","volume":"39","author":"AT Ton","year":"2020","unstructured":"Ton AT, Gentile F, Hsing M, Ban F, Cherkasov A. Rapid identification of potential inhibitors of SARS-CoV-2 main protease by deep docking of 1.3 billion compounds. Mol Inform. 2020;39:1\u20137.","journal-title":"Mol Inform."},{"key":"834_CR138","doi-asserted-by":"crossref","first-page":"1V","DOI":"10.1186\/s12859-020-3379-z","volume":"21","author":"K Pliakos","year":"2020","unstructured":"Pliakos K, Vens C. Drug-target interaction prediction with tree-ensemble learning and output space reconstruction. BMC Bioinformatics. 2020;21:1V.","journal-title":"BMC Bioinformatics"},{"key":"834_CR139","doi-asserted-by":"crossref","first-page":"i821","DOI":"10.1093\/bioinformatics\/bty593","volume":"34","author":"H \u00d6zt\u00fcrk","year":"2018","unstructured":"\u00d6zt\u00fcrk H, \u00d6zg\u00fcr A, Ozkirimli E. DeepDTA: deep drug-target binding affinity prediction. Bioinformatics. 2018;34:i821\u20139.","journal-title":"Bioinformatics"},{"key":"834_CR140","unstructured":"Feng Q, Dueva E, Cherkasov A, Ester M. PADME: a deep learning-based framework for drug-target interaction prediction. 2018;arXiv:1807."},{"key":"834_CR141","doi-asserted-by":"crossref","first-page":"3037","DOI":"10.1021\/acsomega.0c05377","volume":"6","author":"Y Zheng","year":"2021","unstructured":"Zheng Y, Wu Z. A machine learning-based biological drug-target interaction prediction method for a tripartite heterogeneous network. ACS Omega. 2021;6:3037\u201345.","journal-title":"ACS Omega"},{"key":"834_CR142","doi-asserted-by":"crossref","unstructured":"Wang S, Guo Y, Wang Y, Sun H, Huang J. 2019 Smiles-Bert: large scale unsupervised pre-training for molecular property prediction. Proceedings of the 10th ACM international conference on bioinformatics, computational biology and health informatics (BCB '19). New York, USA: Association for Computing Machinery; 2019.","DOI":"10.1145\/3307339.3342186"},{"key":"834_CR143","unstructured":"Mikolov T, Chen K, Corrado G, Dean J. Efficient estimation of word representations in vector space. 1st Int conf learn represent ICLR 2013\u2014Work Track Proc. International conference on learning representations; 2013."},{"key":"834_CR144","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1186\/s12864-018-5370-x","volume":"20","author":"J Du","year":"2019","unstructured":"Du J, Jia P, Dai Y, Tao C, Zhao Z, Zhi D. Gene2vec: distributed representation of genes based on co-expression. BMC Genomics. 2019;20:82.","journal-title":"BMC Genomics"},{"key":"834_CR145","doi-asserted-by":"crossref","first-page":"1735","DOI":"10.1162\/neco.1997.9.8.1735","volume":"9","author":"S Hochreiter","year":"1997","unstructured":"Hochreiter S, Schmidhuber J. Long short-term memory. Neural Comput. 1997;9:1735\u201380.","journal-title":"Neural Comput"},{"key":"834_CR146","doi-asserted-by":"crossref","unstructured":"Guo Z, Yu W, Zhang C, Jiang M, Chawla N V. GraSeq: graph and sequence fusion learning for molecular property prediction. Proceedings of the 29th ACM International Conference on Information & Knowledge Management; 2020.","DOI":"10.1145\/3340531.3411981"},{"key":"834_CR147","unstructured":"\u00d6zt\u00fcrk H, Ozkirimli E, \u00d6zg\u00fcr A. WideDTA: prediction of drug-target binding affinity. 2019. Available from: http:\/\/arxiv.org\/abs\/1902.04166. Accessed 8 July 2024."},{"key":"834_CR148","doi-asserted-by":"crossref","first-page":"625","DOI":"10.3390\/ph14070625","volume":"14","author":"SJG De","year":"2021","unstructured":"De SJG, Fernandes MAC. A novel deep neural network technique for drug\u2014target interaction. Pharmaceutics. 2021;14:625.","journal-title":"Pharmaceutics"},{"key":"834_CR149","doi-asserted-by":"crossref","unstructured":"Kwon S, Yoon S. DeepCCI: end-to-end deep learning for chemical-chemical interaction prediction. Proceedings of the 8th ACM international conference on bioinformatics, computational biology, and health informatics; 2017.","DOI":"10.1145\/3107411.3107451"},{"key":"834_CR150","doi-asserted-by":"crossref","first-page":"3012","DOI":"10.1109\/JBHI.2020.2977091","volume":"24","author":"J Li","year":"2020","unstructured":"Li J, Pu Y, Tang J, Zou Q, Guo F. DeepAVP: a dual-channel deep neural network for identifying variable-length antiviral peptides. IEEE J Biomed Heal Informatics. 2020;24:3012\u20139.","journal-title":"IEEE J Biomed Heal Informatics"},{"key":"834_CR151","doi-asserted-by":"crossref","first-page":"575","DOI":"10.4155\/fmc-2020-0262","volume":"13","author":"N Bung","year":"2021","unstructured":"Bung N, Krishnan SR, Bulusu G, Roy A. De novo design of new chemical entities for SARS-CoV-2 using artificial intelligence. Future Med Chem. 2021;13:575\u201385.","journal-title":"Future Med Chem"},{"key":"834_CR152","doi-asserted-by":"crossref","first-page":"10331","DOI":"10.1038\/ncomms10331","volume":"7","author":"E Guney","year":"2016","unstructured":"Guney E, Menche J, Vidal M, Bar\u00e1basi AL. Network-based in silico drug efficacy screening. Nat Commun. 2016;7:10331.","journal-title":"Nat Commun"},{"key":"834_CR153","first-page":"441","volume-title":"Methods in molecular biology","author":"S Alaimo","year":"2016","unstructured":"Alaimo S, Giugno R, Pulvirenti A. Recommendation techniques for drug\u2013target interaction prediction and drug repositioning. In: Carugo O, Eisenhaber F, editors. Methods in molecular biology. 2nd ed. Hertfordshire: Human Press; 2016. p. 441\u201362.","edition":"2"},{"key":"834_CR154","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1093\/bioinformatics\/bts670","volume":"29","author":"JP Mei","year":"2013","unstructured":"Mei JP, Kwoh CK, Yang P, Li XL, Zheng J. Drug-target interaction prediction by learning from local information and neighbors. Bioinformatics. 2013;29:238\u201345.","journal-title":"Bioinformatics"},{"key":"834_CR155","doi-asserted-by":"crossref","first-page":"2205","DOI":"10.1084\/jem.20122709","volume":"210","author":"P Khatri","year":"2013","unstructured":"Khatri P, Roedder S, Kimura N, De Vusser K, Morgan AA, Gong Y, et al. A common rejection module (CRM) for acute rejection across multiple organs identifies novel therapeutics for organ transplantation. J Exp Med. 2013;210:2205\u201321.","journal-title":"J Exp Med"},{"key":"834_CR156","doi-asserted-by":"crossref","first-page":"S2","DOI":"10.1038\/527S2a","volume":"527","author":"M Eisenstein","year":"2015","unstructured":"Eisenstein M. Big data: the power of petabytes. Nature. 2015;527:S2\u20134.","journal-title":"Nature"}],"container-title":["World Journal of Pediatrics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12519-024-00834-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12519-024-00834-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12519-024-00834-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,2,13]],"date-time":"2025-02-13T16:34:18Z","timestamp":1739464458000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12519-024-00834-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,8,28]]},"references-count":156,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2025,1]]}},"alternative-id":["834"],"URL":"https:\/\/doi.org\/10.1007\/s12519-024-00834-x","relation":{},"ISSN":["1708-8569","1867-0687"],"issn-type":[{"value":"1708-8569","type":"print"},{"value":"1867-0687","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,8,28]]},"assertion":[{"value":"30 January 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 July 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 August 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"No financial or non-financial benefits have been received or will be received from any party related directly or indirectly to the subject of this article.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"Not applicable as this research did not directly involve human subjects or individual case details.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}}]}}